Jersey, 9 March 2021 – With reference to the press release published today by Pfizer regarding the deal with Mercure Investment Sàrl for a loan that will allow the increase of its production capacity to meet with the demands of Europe, up to a maximum amount of Euro 500,000,000, IGLI expresses its approval for the resolution adopted by Mercure International S.A.
As a consequence, IGLI intends to provide its subsidiary Mercure International S.A. with the necessary financial resources.
IGLI controls 100% of Mercure International S.A., which in turn holds 100% of Mercure Investment Sàrl.
